Your browser doesn't support javascript.
loading
Uptake and timing of bilateral prophylactic salpingo-oophorectomy among BRCA1 and BRCA2 mutation carriers.
Bradbury, Angela R; Ibe, Comfort N; Dignam, James J; Cummings, Shelly A; Verp, Marion; White, Melody A; Artioli, Grazia; Dudlicek, Laura; Olopade, Olufunmilayo I.
Afiliação
  • Bradbury AR; University of Chicago Center for Clinical Cancer Genetics, Chicago, Illinois.
  • Ibe CN; Department of Medicine, Section of Hematology-Oncology, University of Chicago, Chicago, Illinois.
  • Dignam JJ; University of Chicago Center for Clinical Cancer Genetics, Chicago, Illinois.
  • Cummings SA; Department of Medicine, Section of Hematology-Oncology, University of Chicago, Chicago, Illinois.
  • Verp M; Department of Health Studies, University of Chicago, Chicago, Illinois.
  • White MA; University of Chicago Center for Clinical Cancer Genetics, Chicago, Illinois.
  • Artioli G; Department of Medicine, Section of Hematology-Oncology, University of Chicago, Chicago, Illinois.
  • Dudlicek L; University of Chicago Center for Clinical Cancer Genetics, Chicago, Illinois.
  • Olopade OI; Department of Obstetrics and Gynecology, University of Chicago, Chicago, Illinois.
Genet Med ; 10(3): 161-166, 2008 Mar.
Article em En | MEDLINE | ID: mdl-18344704
PURPOSE: To evaluate prophylactic salpingo-oophorectomy uptake and timing among BRCA1/2 mutation carriers in a cancer risk assessment program. METHODS: Clinical records of female BRCA1/2 mutation carriers who received cancer genetic counseling between 1996 and 2003 were reviewed to determine the completion and the timing of prophylactic salpingo-oophorectomy. Logistic regression models evaluated associations between subject characteristics and surgery. Survival analysis methods were used to estimate the distribution of time to surgery. RESULTS: Among 88 women, 70% underwent prophylactic salpingo-oophorectomy. Prophylactic salpingo-oophorectomy was associated with older age, white race, having children, and a family history of ovarian cancer. Many women waited more than 12 months to undergo surgery and some delayed by several years. Younger age and not having children were associated with delays to surgery. CONCLUSION: Prophylactic salpingo-ooporectomy is an acceptable risk reduction measure for many BRCA1/2 mutation carriers. Some women make this decision many years after genetic testing. Continued discussion of the risks and benefits of risk reduction options may facilitate the uptake of recommended risk reduction interventions among BRCA mutation carriers.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ovariectomia / Genes BRCA1 / Genes BRCA2 / Tubas Uterinas / Mutação Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Genet Med Assunto da revista: GENETICA MEDICA Ano de publicação: 2008 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ovariectomia / Genes BRCA1 / Genes BRCA2 / Tubas Uterinas / Mutação Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Genet Med Assunto da revista: GENETICA MEDICA Ano de publicação: 2008 Tipo de documento: Article